Electrospun collagen-based nanofibres: A sustainable material for improved antibiotic utilisation in tissue engineering applications

Abstract

For the creation of scaffolds in tissue engineering applications, it is essential to control the physical morphology of fibres and to choose compositions which do not disturb normal physiological function. Collagen, the most abundant protein in the human body, is a well-established biopolymer used in electrospinning compositions. It shows high in-vivo stability and is able to maintain a high biomechanical strength over time. In this study, the effects of collagen type I in polylactic acid-drug electrospun scaffolds for tissue engineering applications are examined. The samples produced were subsequently characterised using a range of techniques. Scanning electron microscopy analysis shows that the fibre morphologies varied across PLA-drug and PLA-collagen-drug samples - the addition of collagen caused a decrease in average fibre diameter by nearly half, and produced nanofibres. Atomic force microscopy imaging revealed collagen-banding patterns which show the successful integration of collagen with PLA. Solid-state characterisation suggested a chemical interaction between PLA and drug compounds, irgasan and levofloxacin, and the collagen increased the amorphous regions within the samples. Surface energy analysis of drug powders showed a higher dispersive surface energy of levofloxacin compared with irgasan, and contact angle goniometry showed an increase in hydrophobicity in PLA-collagen-drug samples. The antibacterial studies showed a high efficacy of resistance against the growth of both E. coli and S. Aureus, except with PLA-collagen-LEVO which showed a regrowth of bacteria after 48h. This can be attributed to the low drug release percentage incorporated into the nanofibre during the in vitro release study. However, the studies did show that collagen helped shift both drugs into sustained release behaviour. These ideal modifications to electrospun scaffolds may prove useful in further research regarding the acceptance of human tissue by inhibiting the potential for bacterial infection.

Evolution of Bioengineered Lung Models: Recent Advances and Challenges in Tissue Mimicry for Studying the Role of Mechanical Forces in Cell Biology

“…However, synthetic polymers lack cell affinity because of their low hydrophilicity and lack of surface cell recognition sites . To overcome this drawback, synthetic‐based materials are often functionalized prior to biological use.…”

Fabrication and characterization of tretinoin-loaded nanofiber for topical skin delivery

“…Both formulations showed a similar biphasic release profile and a burst release in the first 3 h. This demonstrates the dissolution of the drug-loaded on the surface of nanofibers followed by a slow-release phase that may be due to diffusion of drug trapped inside the fibers [20]. Due to the semi-crystalline structure of PCL and its low degradation rate, part of the drug was trapped inside nanofibers which release with polymer degradation over time [21].…”

Characterization of drug delivery vehicles using atomic force microscopy: current status

“…Barrientos et al incorporated irgasan, and separately, levofloxacin (both antibacterial agents) into scaffolds [98]. AFM images showed crystals of levofloxacin on fibre surfaces, but not those of irgasan; in a related paper [99], the same drugs were incorporated with type I collagen and fibril banding on the levofloxacin-containing fibres was observed confirming the deposition of collagen (Fig. 5).…”